Chargement en cours...
Comparison of long‐term use of prolonged‐release ropinirole and immediate‐release dopamine agonists in an observational study in patients with Parkinson's disease
PURPOSE: To estimate the risk of dyskinesia and impulse control disorders (ICDs) in patients with Parkinson's disease (PD) prescribed ropinirole prolonged‐release (R‐PR) compared to those prescribed immediate‐release dopamine agonists (IR‐DA) as monotherapy. METHODS: PD patients initiating R‐PR...
Enregistré dans:
| Publié dans: | Pharmacoepidemiol Drug Saf |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7317950/ https://ncbi.nlm.nih.gov/pubmed/32153056 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.4986 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|